The presence of the FGFR3-TACC3 fusion increases cell proliferation and tumor formation in vivo [35], but confers sensitivity to specific FGFR inhibitors, indicating an oncogenic addiction to the fusion [37, 39, 40]. This evidence concerns the gene FGFR3 and neoplasm.